Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
fda
2
×
life sciences
merck
2
×
national
national blog main
national top stories
new york blog main
abbvie
allergan
amgen
biohaven
biotech
blueprint medicines
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cgpr
companion diagnostic
detroit blog main
detroit top stories
dna sequencing
drugs
eli lilly
entrectinib
europe blog main
express scripts
foundation medicine
indiana blog main
indiana top stories
josh bilenker
keytruda
larotrectinib
loxo oncology
melanie nallicheri
migraine
new england journal of medicine
new york top stories
What
approved
fda
new
2
×
adults
allergan
cancer
class
deeper
dna
drug
fingerprint
genetic
going
matter
medicine
medicines
migraine
monday
nd
nod
oks
pill
second
targets
time
tissues
treat
treatment
tumor's
ubrelvy
ubrogepant
wins
world
Language
unset
Current search:
merck
×
new
×
fda
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
